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Abstract
Early infant diagnosis (EID) of HIV provides an opportunity for early HIV detection and
access to appropriate Antiretroviral treatment (ART). Dried Blood Spot (DBS) samples are
used for EID of exposed infants, born to HIV-positive mothers. However, DBS rejection
rates in Zimbabwe have been exceeding the target of less than 2% per month set by the
National Microbiology Reference Laboratory (NMRL), in Harare. The aim of this study was
to determine the DBS sample rejection rate, the reasons for rejection and the possible asso-
ciations between rejection and level of health facility where the samples were collected. This
is an analytical cross-sectional study using routine DBS sample data from the NMRL in
Harare, Zimbabwe, between January and December 2017.A total of 34 950 DBS samples
were received at the NMRL. Of these, 1291(4%) were rejected. Reasons for rejection were
insufficient specimen volume (72%), missing request form (11%), missing sample (6%),
cross-contamination (6%), mismatch of information (4%) and clotted sample (1%). Samples
collected from clinics/rural health facilities were five times more likely to be rejected com-
pared to those from a central hospital. Rejection rates were above the set target of <2%.
The reasons for rejection were ‘pre-analytical’ errors including labelling errors, missing or
inconsistent data, and insufficient blood collected. Samples collected at primary healthcare
facilities had higher rejection rates.
Introduction
Prevention of mother-to-child transmission (PMTCT) of HIV is one of the most important
challenges in the global elimination of paediatric HIV infection [1, 2]. WHO recommends
EID to be performed as part of the PMTCT cascade on HIV-exposed infants within four to six
weeks of age [1].
In February 2013, Zimbabwe’s Ministry of Health and Child Care (MoHCC) adopted
Option B+, the implementation of lifelong ART for all pregnant and breastfeeding HIV-posi-
tive mothers, regardless of CD4 count and clinical stage [3]. This policy change represented a
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paradigm shift in the implementation of PMTCT and ART programmes. However, only half
(51%) of the HIV-exposed infants has access to EID-testing at age six to eight weeks or at earli-
est possible opportunity [1]. If the EID-test is negative at 6–8 weeks and the risk of HIV-expo-
sure through breast feeding continues, the test must be repeated at weaning. Thereafter, a
rapid test carried out after 18 months of age will provide the definitive diagnosis [4]. Early ini-
tiation of ART within the first 12 weeks of life, has shown a 75% reduction in AIDS related ill-
ness and mortality [4, 5].
Dried Blood Spot (DBS) samples are preferred to EDTA anticoagulated whole blood sam-
ples for EID-testing because they permit infant HIV-testing even in areas with limited
resources for collection, storage and transportation of blood samples. DBS samples are col-
lected by pricking the heel of the infant using a blood lancet, dripping the blood onto the five
circles of a DBS card (see Fig 1), and leave to dry for two to four hours on a dry and dust-free
surface before packaging and sending it by courier to the National Microbiology Reference
Laboratory (NMRL) in Harare.
NMRL is one of the few laboratories in Zimbabwe that tests EID DBS samples using Roche
AmpliPrep/Cobas TaqMan 96 analyzer with technological capability of analysing one full spot
protocol for testing. Box 1 outlines NMRL DBS rejection criteria.
Fig 1. Five circles blood spot card.
https://doi.org/10.1371/journal.pone.0210136.g001
Box 1. DBS rejection criteria at NMRL.
1. Incomplete identification on the request and/or DBS card;
2. DBS card without request form/Request form without DBS card;
3. Specimens with evidence of contamination, leakage or spillage in transit;
4. DBS sample with traces of blood clots or clumps;
5. DBS sample with less than 3 full circles (insufficient).
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The laboratory rejects all samples that meet the criteria listed in Box 1.
Fig 1 below shows a DBS sample accepted for testing. All samples that did not meet the vol-
ume criteria were rejected.
There is evidence that insufficient volume of specimen is one of the major reasons for the
high DBS sample rejection rate. It is unclear why this is the case, given that the evidence also
suggests that the technology for testing DBS samples can analyse and produce conclusive
results from a minimum of two insufficient spot samples [6]. DBS sample rejection may lead
to missed diagnostic opportunities (MDO) in EID eligible infants. Insufficient sample volume
is not the only contributing factor to DBS sample rejection. Others include poor sample collec-
tion techniques, poor documentation of both samples and request forms, and inconclusive
results on assay in the laboratory.
These issues are not unique to the Zimbabwean PMTCT and ART programme. Compara-
ble programmes in other African countries reported similar problems and it is estimated that
sample collection errors account for 60–70% of all rejections [7]. A few examples: the results of
a study carried out in South Africa showed that 3.7% of samples were rejected due to ‘pre-ana-
lytical’ errors including labelling errors, sample damage, missing or inconsistent data, and
insufficient volume [8]. Similarly, in a study conducted in Nigeria, the main reasons for rejec-
tion were poor collection technique (26.3%), improper labelling (16.4%) and insufficient blood
collection (14.8%) [9]. The same study also showed that DBS collected at primary and second-
ary health care level were two to three times more likely to be rejected than those collected in
tertiary healthcare facilities [10].
In Zimbabwe, feedback from NMRL to submitting healthcare facilities can take up to four-
teen days from sample collection [11]. It takes a further few weeks before the healthcare facility
informs the mother-baby pair that the sample was rejected and that a new DBS sample is
required [10]. Inevitably, this results in delayed diagnosis and treatment of HIV-infected
infants, MDO and subsequently loss to follow-up.
The lack of laboratory surveillance in Zimbabwe to monitor and track EID-related pro-
cesses has been a cause for concern. In addition, there are very few studies that investigate the
reasons for DBS rejection [6]. The absence of data on DBS rejection rates means that informa-
tion about appropriate and corrective actions to improve the EID-programme and reduce loss
to follow-up is limited.
The aim of this study was to determine the proportion of DBS samples sent to the NMRL
and rejected between January and December 2017 and the reasons for this rejection.
Methods
Study design
A cross- sectional study that used routine data from EID-laboratory information management
system (LIMS). DBS samples collected from all facilities in 5provinces of Zimbabwe and sent
to NMRL were logged into EID-LIMS. Records of rejected samples in EID-LIMS were vali-
dated against source hard copy documents. Descriptive analysis was performed to describe the
variables in relation to number and proportion of rejected DBS, reasons for rejection and level
of the health facilities.
Study setting
General setting. Zimbabwe is a country in Southern Africa, with a population of 17 mil-
lion people in 2017 [11]. The country is divided into 8 provinces and 2 cities that are also prov-
inces (Bulawayo and Harare).
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It has a four-tiered health care system, which includes (i) the primary health care facilities
(predominantly rural health centres and polyclinics), (ii) district health centres (including mis-
sion hospitals), (iii) provincial hospitals and (iv) tertiary referral or central hospitals. EID-sam-
ples from health facilities located in 5 provinces (Harare, Mashonaland West, Mashonaland
East, Mashonaland Central and Midlands Provinces) are tested at NMRL. The results are sub-
sequently returned to the facility for initiation of treatment and care of the infants.
Specific setting. The NMRL is based in Harare. It was established in 2007 and is the first
accredited laboratory to perform HIV DNA PCR. Until 2013, NMRL was the only laboratory
that processed DBS samples for EID nationally. In 2013, the Zimbabwean government decen-
tralised laboratory services. This means that the NMRL now only processes EID- samples from
5 provinces while the laboratories from Mpilo and Mutare process EID-samples from nearby
health facilities. This study analysed the DBS sample rejection rate of samples from these 5
provinces sent to the NMRL.
Box 1 shows the criteria for rejection.
DBS samples that met the above criteria were rejected and the laboratory conveyed feed-
back, including reason for rejection, to the health facility. The health facility in turn, contacted
the care provider requesting another sample.
Study population and period. DBS samples collected from HIV-exposed infants from all
facilities in the five provinces and sent to NMRL between January and December 2017, were
included in the study.
Data collection and validation. Data on rejected samples from the EID-LIMS were vali-
dated against source documents of the rejected DBS samples that were kept as hard copies.
The data extraction was done cumulatively and disaggregated by health facility on a monthly
basis. Variables collected included: date of sample receipt; number of the laboratory request
form; total number of DBS samples received; total number of rejected samples; number of
samples rejected by health facility level; health facility name, level, district, and province of
rejected DBS samples; reason for rejection (S1 Fig).
Data analysis and statistics. Descriptive analysis was conducted to describe the variables
in relation to number and proportion of rejected DBS samples, reasons for rejection and level
of the referring health facility. The Chi square test was performed using STATA version 13
(Stata Corp, Texas USA) and presented as odd ratios (OR) with 95% confidence intervals (CI).
Differences at 5% level were regarded as significant
Ethical considerations. Ethical approval: Permission to conduct the study was obtained
from the Director of NMRL, the Union Ethics Review Committee (reference number EAG/
07/18) and the Medical Research Council of Zimbabwe (Ethical approval reference number
MRCZ/E/194).
Results
Between January and December 2017, 34 950 DBS samples were received at the NMRL, 1291
(4%) samples were rejected. Table 1 shows the proportion of DBS samples rejected by month.
The proportion of rejected samples ranged from 3% to 6% with the highest rejection rate
observed in September.
Table 2 shows the proportion of DBS samples rejected including the level of health facility.
DBS samples collected from clinics or rural health centres, district/faith-based hospitals and
provincial hospital were more likely to be rejected compared to those from a central hospital.
Thirty-four DBS samples for which no reason for rejection was stated on the request form
were excluded from this analysis. The major reason for rejection of DBS samples was insuffi-
cient specimen volume. If there was insufficient blood on all 5 spots of the DBS card, the
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volume was considered inadequate and the sample rejected (Table 3). Other reasons for rejec-
tions were missing request form, missing sample, cross contamination, clotted sample, or mis-
matched information.
Table 4 shows the number and proportion of rejected DBS samples by province. Rejection
rate ranged from 2% to 7% among the 5 provinces. Mashonaland West (7%) and Midlands
Province (4%) showed the highest rejection rates.
Discussion
This is the first study in Zimbabwe’s EID-programme that assesses the magnitude of and rea-
sons for the rejection of DBS samples sent by five provinces to NMRL for analysis. The
national maximum rejection target for DBS samples is<2% per month. This study found that
the NMRL’s rejection rate is above the national target. These findings are similar to those of a
study conducted in KwaZulu Natal province in South Africa where the rejection rate was 4%
[6]. An even higher aggregated EID-programme DBS rejection rate of 7.4% was reported in a
similar study conducted in Mashonaland West province, Zimbabwe, in 2017 [10]. However,
the latter study only investigated one province while our study looked at five provinces.
Analysis showed that samples collected at primary healthcare facilities (rural clinics) where
most patients receive care were five times more likely to be rejected. Findings are similar to a
Nigerian study where the bulk of rejected samples came from facilities that serve most patients
Table 1. Number and proportion of rejected DBS samples at the NMRL, between January and December 2017.
Dried Blood Spot samples
Received Rejected (%)
Total 34 950 1291 (4)
Months
January 4138 105 (3)
February 2959 98 (3)
March 4123 128 (3)
April 3253 114 (4)
May 3533 132 (4)
June 3150 107 (3)
July 2668 106 (4)
August 2593 105 (4)
September 2191 125 (6)
October 2377 125 (5)
November 2189 88 (4)
December 1776 58 (3)
https://doi.org/10.1371/journal.pone.0210136.t001
Table 2. The relationship between DBS samples rejected by the NMRL and the level of health facility from which they were collected between January and Decem-
ber 2017.
Dried Blood Spot samples
Level of health facility Received (%) Rejected (%) Odds Ratio
(95% CI)
Central hospital 1619 (99) 13 (1) 1
Clinic/Rural health centre 31 460 (97) 1089 (3) 4.58 (2.65–7.64)
District/faith-based hospital 5721 (97) 147 (3) 3.37 (1.91–5.95)
Provincial hospital 346 (98) 8 (2) 2.92 (1.20–7.11)
https://doi.org/10.1371/journal.pone.0210136.t002
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[9]. One possible explanation for this higher rejection rate in primary healthcare facilities is
the high demand and the lack of financial resources for staff recruitment and equipment in
these facilities. This may explain the inadequate quality assurance mechanisms when collecting
samples.
The other possible explanation could be that rural facilities are unable to offer adequate “in-
service” staff training. They can only afford to send a small number of staff for training in large
urban centres. Upon return they provide cascade training to the rest of the team. The research
by Smit et al reported that “in-service” cascading of skill is not effective as a training model
because the quality appears to be poorer. Smit et al claim that staff orientation and mentorship
on DBS collection, storage and transportation is essential to standardise skills and improve
DBS sample collection [12]. Their conclusions are consistent with findings from Nkengasong’s
study which showed that sensitising health care workers on sample collection, handling and
completion of laboratory request forms reduced errors from 19.05% to 6.76% [13].
The current study found that a large proportion of the rejections was due to insufficient
blood volume. These findings were consistent with the results of the study in South Africa,
where 48% of all rejection was due to inadequate sample collection [6]. A lower proportion,
i.e. 14.8% of rejection due to insufficient blood collection, was observed in a Nigerian study
[7].
A previous study has shown that for analysis purposes the combination of two insufficient
DBS samples still yields satisfactory results. Govender et al showed that the combined use of
two insufficient spots avoided 10 504 samples being rejected due to insufficient blood volume.
However, there was no denominator available in this study to allow us to determine the pro-
portion of prevented rejections [6].
However, Govender et al conducted a validation study on the modified testing method to
determine if the use of two insufficient DBS protocol can yield the same results as a validated
Table 3. Proportion of DBS samples rejected at the NMRL between January and December 2017, rejection reason and type of health facility.
N (%) Clinic/rural health centre District hospital Provincial hospital Central hospital
Rejected DBS samples 1257 1089 147 8 13
Insufficient 909 (72) 801 (73) 94 (64) 3 (38) 11 (84)
Missing request form 133 (11) 100 (9) 28 (19) 5 (63) 0 (0)
Missing sample 77 (6) 65 (6) 11 (7) 0 (0) 1 (8)
Clotted sample 11 (1) 10 (1) 0 (0) 0 (0) 1 (8)
Mismatched info 52 (4) 42 (4) 10 (7) 0 (0) 0 (0)
Cross contamination 75 (6) 71 (7) 4 (3) 0 (0) 0 (0)
https://doi.org/10.1371/journal.pone.0210136.t003
Table 4. Proportion of rejected DBS samples at NMRL and Provinces, January—December 2017.
Dried Blood Spot samples
Received Rejected (%)
Total 34 950 1291 (4)
Province
Harare 9267 165 (2)
Mash Central 6548 187 (3)
Mash East 8525 337 (3)
Mash West 5197 367 (7)
Midlands 5413 235 (4)
Mash Mashonaland
https://doi.org/10.1371/journal.pone.0210136.t004
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method of one full spot protocol [6]. This study showed that the two insufficient spot protocol
yielded results that are comparable to the validated one full spot protocol. These findings may
lead NMRL to revise its rejection criteria in relation to emerging evidence and consider accept-
ing samples with two full spots.
Furthermore, there has been evidence that implementation of a quality management system
improves identification of flaws of the system while corrective actions eliminate the root causes
of the problems, thereby reducing the sample rejection rate [14, 15].
This study has found that Mashonaland West Province had the highest proportion of
rejected DBS samples, followed by Midlands Province. Further investigation is required to
establish the possible causes.
These rejections may result in MDO of HIV-infected infants, loss to follow-up and delay of
early ART-initiation of HIV-positive infants. DBS rejections also contribute to delays in
accessing laboratory results for EID-testing, have serious implications on the PMTCT pro-
gramme and lives of infants that may need life-long ART [8,10].
Limitations
The EID-programme does not have a unique patient identifier, we were thus unable to track
whether another DBS sample was collected and the extent of the delay in this second
collection.
We were not able to observe the staffing levels and workload of the health facilities that sent
samples to NMRL. Additionally, we could not verify the qualifications, competencies and
training of staff for DBS sample collection. These factors may however have an impact on qual-
ity assurance mechanisms for sample collection
There were no available data to track the interval between sample collection and informing
the mother that the sample had been rejected. Such data could show whether sample rejection
adversely influences early ART-initiation for infants.
Recommendations
• NMRL to monitor the rejection rates and notify the health facility management in real time
to enable corrective and preventive actions and avoid delays due to rejected DBS.
• Revision of the user manual to make it clear that the blood droplet must spread along the
DBS card to reach the marked sections of the circle.
• Develop mentorship programmes on DBS sample collection, storage and transportation
especially in areas where there are high rejection rates.
• As samples probably pass through district laboratories or facilities with laboratories first,
these could evaluate the quality of the samples before sending them to NMRL. This would
allow identification of deficiencies closer to the collection site, and corrective actions could
be taken at district level before sending the sample to the NMRL.
• The quality management system of laboratory processes needs to be strengthened to identify
deficiencies in DBS sample management. It enables corrective actions to reduce sample
rejection rates that impact on patient care.
• NMRL needs to conduct a laboratory validation of “two insufficient spot protocol” against
a” one full spot protocol” so that the rejection criteria can be reviewed based on the scientific
evidence of the validation.
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Conclusions
This study has shown that DBS rejection rates are above the national target. The main reason
for rejection was insufficient volume samples. Clinic/rural health centres have a higher rejec-
tion rate than central hospitals. Overall, there is need to monitor rejection rates in real time, so
that corrective and preventive actions may be taken to reduce or eliminate causes of DBS sam-
ple rejection.
Supporting information
S1 Fig. Data collected on received and rejected dried blood spot specimens at NMRL.
(PDF)
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